Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | APG-1387 |
| Synonyms | |
| Therapy Description |
APG-1387 is a SMAC mimetic, which antagonizes Inhibitor of Apoptosis (IAP) family proteins, potentially resulting in apoptosis of tumor cells and inhibition of tumor growth (PMID: 27424523, PMID: 30459627). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| APG-1387 | APG1387|APG 1387|SM-1387 | SMAC Mimetic 8 | APG-1387 is a SMAC mimetic, which antagonizes Inhibitor of Apoptosis (IAP) family proteins, potentially resulting in apoptosis of tumor cells and inhibition of tumor growth (PMID: 27424523, PMID: 30459627). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03386526 | Phase Ib/II | APG-1387 | APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies | Completed | USA | 0 |